Hence, it seems that worse prognosis of RTI-positive CS I seminoma patients, manifested as a weak response to CDDP-based chemotherapy, could be associated, at least in part, with low levels of mitochondrially localized PARK7, which may be a result of overall low levels of retained PARK7. This evidence concerns the gene PARK7 and seminoma.